Reported 2 days ago
Tandem Diabetes Care, Inc. has agreed to pay Roche $36 million to settle a patent infringement lawsuit related to its t:slim X2 insulin pump. The settlement covers two European patents and ends all ongoing legal proceedings in France and Germany. Tandem will make an initial payment of $8 million followed by four annual installments of $7 million, and both companies will enter a cross-license agreement that lasts ten years.
Source: YAHOO